Sutro Biopharma wants to use its antibody-drug conjugates (ADCs) as “laser-guided weapons” against cancer cells while sparing the surrounding ones and therefore patients’ quality of life. “I like to think of antibody-drug conjugates as kind of laser-guided weapons against tumor cells. And then what we can do, and Sutro is very focused on this, is […]

New York-based COVAXX announced on January 8, 2021, it has initiated preclinical work on a second vaccine candidate to address the latest mutations of the SARS-CoV-2 coronavirus responsible for COVID-19, and specifically the South African mutation. The COVAXX multitope vaccine is being developed using high precision, commercially proven, and scalable synthetic peptide-based vaccine platform, designed to activate […]

Immunotherapy, sometimes using living cell therapeutics, has been a huge medicinal advance, but one that falls short in one key area: dosage. CAR-T and other cell and gene therapies lacked the ability to tune dosage up or down based on patient response. The therapies were either on or off, all or nothing. Obsidian Therapeutics, Inc. […]